Cargando…

Monitoring Radiographic Brain Tumor Progression

Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Ankit I., Kanaly, Charles W., Friedman, Allan H., Bigner, Darell D., Sampson, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202817/
https://www.ncbi.nlm.nih.gov/pubmed/22069705
http://dx.doi.org/10.3390/toxins3030191
_version_ 1782215038793154560
author Mehta, Ankit I.
Kanaly, Charles W.
Friedman, Allan H.
Bigner, Darell D.
Sampson, John H.
author_facet Mehta, Ankit I.
Kanaly, Charles W.
Friedman, Allan H.
Bigner, Darell D.
Sampson, John H.
author_sort Mehta, Ankit I.
collection PubMed
description Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression.
format Online
Article
Text
id pubmed-3202817
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-32028172011-11-08 Monitoring Radiographic Brain Tumor Progression Mehta, Ankit I. Kanaly, Charles W. Friedman, Allan H. Bigner, Darell D. Sampson, John H. Toxins (Basel) Review Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression. MDPI 2011-03-15 /pmc/articles/PMC3202817/ /pubmed/22069705 http://dx.doi.org/10.3390/toxins3030191 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Mehta, Ankit I.
Kanaly, Charles W.
Friedman, Allan H.
Bigner, Darell D.
Sampson, John H.
Monitoring Radiographic Brain Tumor Progression
title Monitoring Radiographic Brain Tumor Progression
title_full Monitoring Radiographic Brain Tumor Progression
title_fullStr Monitoring Radiographic Brain Tumor Progression
title_full_unstemmed Monitoring Radiographic Brain Tumor Progression
title_short Monitoring Radiographic Brain Tumor Progression
title_sort monitoring radiographic brain tumor progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202817/
https://www.ncbi.nlm.nih.gov/pubmed/22069705
http://dx.doi.org/10.3390/toxins3030191
work_keys_str_mv AT mehtaankiti monitoringradiographicbraintumorprogression
AT kanalycharlesw monitoringradiographicbraintumorprogression
AT friedmanallanh monitoringradiographicbraintumorprogression
AT bignerdarelld monitoringradiographicbraintumorprogression
AT sampsonjohnh monitoringradiographicbraintumorprogression